Mankind Pharma Limited has informed the Exchange about Sale or disposal
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma's Board has approved the closure and winding-up of Mankind Pharma Lanka (Private) Limited, its wholly-owned subsidiary in Sri Lanka. The company cited changed regulatory requirements in Sri Lanka that have made the originally anticipated business objectives no longer viable. The subsidiary has not carried out any business operations since incorporation and is not classified as a material subsidiary of the company. No sale consideration, buyer, or transaction value is involved as the entity is being wound up rather than sold.
This is a routine housekeeping action with no material financial impact on Mankind Pharma, since the Sri Lankan subsidiary had no operations and was not a material subsidiary. Shareholders are unlikely to see any meaningful effect on revenue, earnings, or stock price from this announcement.